We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

124 hedge funds and large institutions have $1.32B invested in Ironwood Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $6.05M | Put options by funds: $3.37M

18% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 39

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

1% more capital invested

Capital invested by funds: $1.32B → $1.32B (+$7.57M)

0% more funds holding

Funds holding: 124 → 124 (0)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
124
Holders Change
–
Holders Change %
0%
% of All Funds
3.6%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
15
Increased
46
Reduced
39
Closed
13
Calls
$6.05M
Puts
$3.37M
Net Calls
+$2.69M
Net Calls Change
+$1.23M

Top Buyers

1
BI
BVF Inc
California
+$18M
2
Deutsche Bank
Deutsche Bank
Germany
+$14.2M
3
TI
Turner Investments
Pennsylvania
+$10.4M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$9.25M
5
Wells Fargo
Wells Fargo
California
+$3.79M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$12.4M
2
Millennium Management
Millennium Management
New York
-$9.22M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.11M
4
CCP
Clough Capital Partners
Massachusetts
-$7.27M
5
CGT
Capital Guardian Trust
California
-$4.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$173M +$153K +17,075 +0.1%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$158M +$3.01M +334,772 +2%
BI
3
BVF Inc
California
$111M +$18M +2,005,428 +21%
Morgan Stanley
4
Morgan Stanley
New York
$97.3M -$12.4M -1,377,327 -12%
State of Wisconsin Investment Board
5
State of Wisconsin Investment Board
Wisconsin
$71.6M +$9.25M +1,030,559 +16%
JHIU
6
Janus Henderson Investors US
Colorado
$66.4M +$1.67M +185,510 +3%
Vanguard Group
7
Vanguard Group
Pennsylvania
$65.8M +$1.88M +209,118 +3%
SAM
8
Sectoral Asset Management
Quebec, Canada
$59M +$3.06M +340,470 +6%
Deutsche Bank
9
Deutsche Bank
Germany
$56M +$14.2M +1,577,368 +38%
BFA
10
BlackRock Fund Advisors
California
$46M +$1.08M +120,702 +3%
State Street
11
State Street
Massachusetts
$34.4M -$1.5M -167,636 -5%
BIT
12
BlackRock Institutional Trust
California
$32.6M +$1.25M +139,004 +4%
Capital World Investors
13
Capital World Investors
California
$23.2M – – –
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$22.9M +$2.81M +312,892 +15%
CGT
15
Capital Guardian Trust
California
$22.6M -$4.91M -547,331 -19%
VM
16
VHCP Management
New York
$20.9M – – –
Northern Trust
17
Northern Trust
Illinois
$15.6M +$198K +22,093 +1%
WRF
18
Waddell & Reed Financial
Kansas
$14.8M -$4.22M -470,269 -24%
OIM
19
Oracle Investment Management
Connecticut
$12.6M -$268K -29,850 -2%
TI
20
Turner Investments
Pennsylvania
$11.2M +$10.4M +1,155,291 New
Norges Bank
21
Norges Bank
Norway
$9.99M – – –
RNS
22
Robert N. Shapiro
$9.76M – – –
Adage Capital Partners
23
Adage Capital Partners
Massachusetts
$9.76M -$9.11M -1,015,139 -50%
TG
24
TCW Group
California
$9.7M -$3.45M -384,549 -28%
Fidelity International
25
Fidelity International
Bermuda
$9.6M – – –
1
2 3 4 5

IRWD Hedge Fund Activity: Q4 2013 in Review

124 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2013, worth a combined $1.32B — up 0.58% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IRWD positions and 13 closed out — a net gain of 2 holders — while 46 added to existing stakes and 39 trimmed.

The largest buyer was BVF Inc, adding an estimated $18M. The largest seller was Morgan Stanley, cutting an estimated $12.4M.

  • 124 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $1.32B of Ironwood Pharmaceuticals stock for Q4 2013, up 0.58% quarter-over-quarter.
  • 15 funds opened new Ironwood Pharmaceuticals positions in Q4 2013 and 13 closed out, a net change of +2 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2013 was BVF Inc, an estimated $18M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2013 was Morgan Stanley, an estimated $12.4M sold.

Based on aggregated 13F filings for Q4 2013.